# Psychedelic medicine research and clinical development

> Live situation record from CLSTR: https://clstr.news/situations/psychedelic-medicine-research-and-clinical-development
> Updated: 2026-08-22T15:00:16.000Z. Sources: 5. Developments: 2.

The psychedelic medicine industry is transitioning toward models focused on neuroplasticity, suggesting therapeutic benefits may arise from changes in brain wiring rather than the hallucinogenic experience itself. This shift aims to lower treatment costs by potentially reducing the need for intensive psychotherapy and constant supervision.

While companies like Compass Pathways and GH Research continue Phase 3 trials for substances like psilocybin and MDMA intended for supervised clinical use, new research is clarifying how these substances affect the brain. A study led by Monash University and published in Nature found that psilocybin reorganizes brain activity patterns by reducing the separation between specialized brain networks, making previously distinct regions more connected. The research noted that these effects are influenced by the specific context and activity of the individual.

## Claims

- The study was led by Monash University in Australia. (corroborated by 3 sources)
- The research findings were published in the journal Nature. (corroborated by 3 sources)
- Psilocybin causes brain regions that normally function separately to become more connected. (corroborated by 3 sources)
- The substance does not act the same in all brains but depends on context and activity. (corroborated by 3 sources)
- The study analyzed the brain activity of 62 healthy adults under the influence of psilocybin. (corroborated by 3 sources)
- Psilocybin reorganizes brain activity patterns rather than causing pure chaos. (corroborated by 3 sources)

## Timeline

### 2026-08-22: Monash University study reveals psilocybin reorganizes brain activity

A Monash University study published in Nature reveals that psilocybin reorganizes brain activity and increases connectivity between networks rather than causing chaos, depending on the user's context.

5 sources. https://clstr.news/cluster/monash-university-study-reveals-psilocybin-reorganizes-brain-activity

### 2026-08-10: Psychedelic medicine industry shifts toward neuroplasticity and clinical models

The psychedelic medicine field is splitting between traditional supervised hallucinogenic sessions and a new clinical focus on neuroplasticity to reduce treatment complexity and costs.

2 sources. https://clstr.news/cluster/psychedelic-medicine-industry-shifts-toward-neuroplasticity-and-clinical-models

---
Cite as: Psychedelic medicine research and clinical development. CLSTR, https://clstr.news/situations/psychedelic-medicine-research-and-clinical-development